Your browser doesn't support javascript.
loading
Understanding the Relationship Between Antiviral Prescription Data and COVID-19 Incidence in New York City: A Retrospective Cohort Study.
Kaul, Christina M; Cohen, Gabriel M; Silverstein, Matthew; Wallach, Andrew B; Diago-Navarro, Elizabeth; Holzman, Robert S; Foote, Mary K.
Afiliação
  • Kaul CM; NYU Grossman School of Medicine, New York, New York, USA.
  • Cohen GM; NYU Grossman School of Medicine, New York, New York, USA.
  • Silverstein M; New York City Department of Health and Mental Hygiene, New York, New York, USA.
  • Wallach AB; NYU Grossman School of Medicine, New York, New York, USA.
  • Diago-Navarro E; New York City Department of Health and Mental Hygiene, New York, New York, USA.
  • Holzman RS; NYU Grossman School of Medicine, New York, New York, USA.
  • Foote MK; New York City Department of Health and Mental Hygiene, New York, New York, USA.
Open Forum Infect Dis ; 10(6): ofad281, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37333721
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has caused more than 675 million confirmed cases and nearly 7 million deaths worldwide [1]. While testing for COVID-19 was initially centered in health care facilities, with required reporting to health departments, it is increasingly being performed in the home with rapid antigen testing [2]. Most at-home tests are self-interpreted and not reported to a provider or health department, which could lead to delayed reporting or underreporting of cases [3]. As such, there is a strong possibility that reported cases may become a less reliable indicator of transmission over time.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article